Series B Funded Startups in Belgium
Twenty-one disclosed Series B rounds in Belgium (latest 2026-01-14, earliest 2021-04-01) show a clear size skew: Confo Therapeutics raised $65M on 2024-07-…
Twenty-one disclosed Series B rounds in Belgium (latest 2026-01-14, earliest 2021-04-01) show a clear size skew: Confo Therapeutics raised $65M on 2024-07-26, which sits just above Aikido Security’s $60M on 2026-01-14, while several other rounds are clustered notably below $40M (for example, Nobi at $37M on 2025-01-28 and eTheRNA immunotherapies at $39M on 2022-08-23). An outlier on the downside appears in Agriculture and Farming: BOTALYS raised only $690K on 2023-05-22 versus the broader range of $9M–$88M across the remaining entries (e.g., Precirix at $88M on 2022-03-16). The city pattern also concentrates activity around Brussels and the Flemish cities of Ghent and Antwerp, with multiple rounds headquartered in Brussels (Fyteko 2025-02-13 $14M, Confo Therapeutics 2024-07-26 $65M, Precirix 2022-03-16 $88M, Qover 2021-04-27 $25M, and several more). Sector-wise, Biotechnology is over-represented among these 21 entries, spanning companies such as Animab, Fyteko, Confo Therapeutics, Novadip Biosciences, eTheRNA immunotherapies, AgomAb Therapeutics, and Precirix.
Most recent rounds
21 shownRelated listings
Frequently asked
Which disclosed round is largest here, and how far above the next-highest disclosed amounts does it sit?
The largest disclosed round is Precirix at $88M on 2022-03-16. The next-highest disclosed amount is Confo Therapeutics at $65M on 2024-07-26, meaning the top round is substantially larger than the rest of the list’s upper tier.
Are there obvious outliers in deal size within these Series B rounds?
BOTALYS is a clear downside outlier at $690K on 2023-05-22. At the upper end, Precirix’s $88M (2022-03-16) and Confo Therapeutics’ $65M (2024-07-26) sit well above the $39M–$43M range that includes eTheRNA immunotherapies ($39M, 2022-08-23) and TechWolf ($43M, 2024-06-24).
Where is the concentration by headquarters city: does Belgium’s capital or certain Flemish cities dominate?
Brussels appears repeatedly across sectors and dates: Fyteko ($14M, 2025-02-13), Confo Therapeutics ($65M, 2024-07-26), Precirix ($88M, 2022-03-16), eTheRNA immunotherapies’ district Jette ($39M, 2022-08-23), and Qover ($25M, 2021-04-27) all show Brussels-based rounds. Antwerp and Ghent also recur, including Nobi ($37M, 2025-01-28; city: Antwerpen) and Aikido Security ($60M, 2026-01-14; city: Ghent).
Does one sector clearly dominate this set of Series B rounds?
Biotechnology is the most common sector in this list, appearing in Animab ($12M, 2025-07-01), Fyteko ($14M, 2025-02-13), Confo Therapeutics ($65M, 2024-07-26), Novadip Biosciences ($23M, 2022-11-03), eTheRNA immunotherapies ($39M, 2022-08-23), AgomAb Therapeutics ($39M, 2022-07-13), and Precirix ($88M, 2022-03-16).
How tightly are rounds clustered in time at the top end of the series B window?
The newest entries cluster across late 2025 into early 2026: Aikido Security closed on 2026-01-14 ($60M), with Nobi on 2025-01-28 ($37M) and Animab on 2025-07-01 ($12M) spanning most of 2025. The date coverage runs from 2021-04-01 (AppTweak, $22M) through 2026-01-14.
Are there any sectors that show large mid-tier financing rather than just small rounds?
Hardware and Information Technology each include sizable rounds alongside smaller ones: Spectricity raised $17M on 2021-08-03 (Hardware) while Aikido Security raised $60M on 2026-01-14 (Information Technology). In contrast, the lowest disclosed size comes from Agriculture and Farming via BOTALYS at $690K (2023-05-22).
Know who just raised. Then know who to call.
Every newly funded startup with its round, its investors, and its founders — delivered weekly, or searchable back to 2020.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.